How to Live Longer (with the help of AI) – a Panel of Experts Predict and Advise

Tina Woods

Tina is Founder and CEO of Collider Health, an ecosystem builder that works with organisations in both private and public sectors to transform health with sustainable impact at scale. Tina specialises in connecting government, business and academia to align thinking and take action. She works with the National AHSN AI Network to support an AI and data-driven tech ecosystem for the NHS and UK Research & Innovation on the Healthy Ageing Industrial Strategy Challenge Fund. Tina is also co-founder and CEO of Longevity International, which provides the Secretariat for the All Party Parliamentary Group for Longevity that launched The Health of the Nation Strategy supported by Rt Hon Matt Hancock MP, Secretary of State for Health and Care, in February 2020  to deliver th government manifesto for 5 extra years of healthy life expectancy to all British citizens by 2035 while mimimising health inequalities.  Tina is now setting up the Business Coalition for a Healthier Nation, (a key recommendation in the Strategy) that sets out how business should invest long-term in sustainable preventative health in line with ESG mandates like for climate change:  to enhance  health and economic resilience and develop socially-driven products and services to keep people healthy and well. Tina’s book, ‘Live Longer with AI: How artificial intelligence is helping us extend our healthspans and live better too’  will be published on 9 October (pre-order sales on Amazon here).

Professor Peter Piot

Professor Peter Piot KCMG MD PhD, is the Director of the London School of Hygiene & Tropical Medicine and Handa Professor of Global Health.  He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations (1995-2008).

A clinician and microbiologist by training, Professor Piot co-discovered the Ebola virus in Zaire in 1976, and conducted pioneering research on HIV/AIDS, particularly in Africa. He is the Chair of the UK’s Strategic Coherence of ODA-funded Research Board, London; of the King Baudouin Foundation USA, New York; and of the African Health Research Institute, Durban. He is Vice-Chair of the Global Health Innovation Technology Fund, Tokyo, and member of the Board of the Novartis Foundation, Basel; the Coalition for Epidemic Preparedness Innovation, and Sentebale. He is a Special Advisor to the President of the European Commission on research and innovation for COVID-19.

He was knighted as KCMG in the UK, made a Baron in his native Belgium, and was awarded a Grand Cordon of the Order of the Rising Sun of Japan. He has received numerous awards for his research and service, and has published over 600 scientific articles and 16 books, including his memoir, No Time to Lose, translated into 5 languages.

Dr Indra Joshi

Dr Indra Joshi is the Director of AI for NHSX,  leading on  the creation of the NHS AI Lab. Her other responsibilities include overseeing digital health initiatives within the NHS with a focus on data, digital health standards and evidence. Indra has a unique portfolio with experience stretching across policy, digital health, national project strategy and implementation; whilst remaining true to her professional training as an emergency medic. She is a Founding Member of One HealthTech – a network which campaigns for the need  and importance of better inclusion of all backgrounds, skillsets and disciplines in health technology. Alongside she is a an international speaker and consultant on digital health, an expedition medic, and most importantly a mum to two wonderful little munchkins.

Dr Alex Zhavoronkov

Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery, biomarker development. He is also the founder and CEO of Deep Longevity, Inc, a global company developing a broad range of artificial intelligence-based biomarkers of aging and longevity. Since 2015 he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for generation of the novel molecular structures with the desired properties and generation of synthetic biological and patient data. He also pioneered the applications of deep learning technologies for prediction of human biological age using multiple data types, transfer learning from aging into disease, target identification, and signaling pathway modeling. Under his leadership Insilico raised over $50 million in multiple rounds from expert investors, opened R&D centers in 6 countries and regions, and partnered with multiple pharmaceutical, biotechnology, and academic institutions. Prior to founding Insilico, he worked in senior roles at ATI Technologies (acquired by AMD in 2006), NeuroG Neuroinformatics, Biogerontology Research Foundation. Since 2012 he published over 130 peer-reviewed research papers, and 2 books including “The Ageless Generation: How Biomedical Advances Will Transform the Global Economy” (Palgrave Macmillan, 2013). He serves on the editorial boards of Aging Research Reviews, Aging, Trends in Molecular Medicine, Frontiers in Genetics, and co-chairs the Annual Aging Research, Drug Discovery and AI Forum (7th annual in 2020) at Basel Life, one of Europe’s largest industry events in drug discovery. He is the adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.

Professor Nicola Palmarini

Professor Nicola Palmarini is the Director of UK’s National Innovation Centre for Ageing (NICA). Before, he was research manager at the MIT-IBM Watson AI Lab, a $250 million academic-industry partnership for the responsible advancement of artificial intelligence. Trained in social studies and business communication, he developed a deep expertise in leading heterogeneous teams and connecting dots across disciplines to bridge academic and industrial research with real-world applications to deliver return-on-community and return-on-business with a specific focus on longevity and the coming effects and opportunities of the demographic revolution. He holds a decade of experience in research on supporting older adults’ autonomy and independence, leading a global team to develop Human Activity Recognition techniques dedicated to older adults based on AI applied to IoT data. He is an author, teacher, applied research scientist and his main areas of research are: Loneliness as accelerator of physical and cognitive diseases, Ageism, Aging & economic factors, Aging women and workplace, Ethics and AI. The work of his teams has been awarded two times with the ComputerHonors Award, at the United Nations for Aging Initiative and received the Disability Matters – Market Place Award.
He is the author of five books and member of several boards included the Scientific Advisory Committee at McMaster Institute for Research on Aging (MIRA), GIMI (Global Management Innovation Institute) and the Scientific Board of Political Sciences and International Relations at Università Cattolica del Sacro Cuore of Milan.